Business
Exercise of Warrants and Loan Conversion
Alkemy Capital Investments Plc has received £1,020,819 from the exercise of various warrants and a £250,000 loan conversion, including £4,932 in interest, which will bolster working capital for its advanced FEED study. The company will issue 605,155 new ordinary shares, bringing the total to 10,572,020 shares upon admission on December 3, 2025. This funding is crucial for completing the FEED study and progressing towards asset-level finance arrangements, with construction anticipated in the first quarter of the new year. Disclaimer*
About this update from Alkemy Capital Investments Plc
[{"type":"text","content":"\n\n27 November 2025\n \nAlkemy Capital Investments Plc\nExercise of Warrants and Loan Conversion\n \nAlkemy Capital Investments Plc (\"Alkemy\" or the \"Company\") (LSE: ALK) (JV2:FRA) has received notice to exercise the following warrants:\n· 18,320 broker warrants of £1.00 each, which were issued as per the RNS dated 18 December 2023, resulting in the receipt of £18,320;\n· 166,000 investor warrants of £2.00 each and 50,000 broker warrants of £1.25 each, which were issued as per the RNS dated 17 February 2025, resulting in the receipt of a further £394,500;\n· 253,333 investor warrants of £2.25 each and 25,333 broker warrants of £1.50 each, which were issued as per the RNS dated 25 June 2025, resulting in the receipt of a further £607,999.\nAccordingly a total of £1,020,819 has been received from warrant exercises which will help fund working capital as the Company completes its FEED study which is now well advanced.\nThe Company has also received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £250,000 of principal and £4,932 of interest is being converted at £2.77, resulting in the issue of 92,169 ordinary shares of 2 pence each in the Company (\"Ordinary Shares\").\nThe Company will accordingly issue 605,155 new Ordinary Shares in the Company (the \"New Ordinary Shares\") and following the completion of these warrant exercises and the loan conversion the Company will have 10,572,020 Ordinary Shares in issue.\nChairman of Alkemy, Paul Atherley, commented:\n \n\"We very much welcome the overwhelming support the Company has had from its warrant holders with the majority of outstanding warrants available for conversion having been converted, providing the company with over £1 million in working capital to complete the FEED study ahead of the main finance, which is anticipated to occur in the first quarter of the new year.\n \nThe FEED study is progressing well with a strong focus on reducing the already low capital and operating costs making Tees Valley Lithium internationally highly competitive.\n \nTees Valley Lithium has engaged ABG Sundal Collier to arrange the asset level finance and the low capital cost and strong operating margins, we believe, are making the project hi...